News and updates

An investment into life: we start a crowdfunding campaign via the platform Seedmatch – with prominent support!

Those who have once been suspected to suffer from a severe disease know all-too-well, how long and grueling it can be to wait for further examinations that might bring clarity. […]

Read more
/by

Oncgnostics GmbH cooperates with SAYRE Therapeutics in India

oncgnostics cooperates with Sayre

Bangalore/Jena, 28.04.2016 – The biotech firm oncgnostics GmbH will start distributing its molecular diagnostic test GynTect for use in cervical cancer diagnostics in an exclusive partnership with Sayre Therapeutics. GynTect […]

Read more
/by

Greiner Bio-One starts international marketing of the cervical cancer triage test GynTect

Jena / Frickenhausen, January 20th, 2016 – With the start of 2016 the distribution of the cervical cancer triage test GynTect® by Greiner Bio-One has started. For this purpose the […]

Read more
/by

Fast and reliable results in cancer diagnostics: Biotech startup oncgnostics receives CE mark for cervical cancer test „GynTect“

Jena (Germany), September 18th, 2015 – A new test for use in cervical cancer screening is CE-IVD marked in whole Europe with immediate effect. It may quickly yield reliable test […]

Read more
/by